检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

A phase 1b/2a study of safety and efficacy of NT-I7 in combination with anti-PD-L1 (atezolizumab) in patients with anti-PD-1/PD-L1 naive or relapsed/refractory (R/R) high-risk skin cancers: The phase 1b report.

Brian Gastman,Steven Fling,George Ansstas,Pauline Funchain,Ann W. Silk,Philip Adam Friedlander,Brendan D. Curti,Yan Xing, Oanh Nguyen, Ann Christensen,Sara Ferrando-Martinez,Andreanne Lacroix,Byung Ha Lee,David M. Miller, Jeffrey A. Sosman,Jean Fan

JOURNAL OF CLINICAL ONCOLOGY（2022）

引用 1|浏览12
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要